- Contractors
- Chrysalis Biotherapeutics, Inc.
Chrysalis Biotherapeutics, Inc.
Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)
Chrysalis Biotherapeutics has 1 federal contract of $100,000 or more active since October 2023, with $13M obligated, from 1 agency. None is running now.
- Contracts
- 1 since FY2024$13,030,326 obligated, contracts of $100,000 or more
- Running now
- None
- Biggest customer
- Office of Assistant Secretary for Preparedness and Response$13M on 1 contract
- Main industry
- Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714
- UEI
- XW1VFGGRLDW3Unique entity ID in SAM.gov
- Source
- USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC
Running contracts
No contract of $100,000 or more is running now.
Who they work for
| Agency | Amount | Share |
|---|---|---|
| Office of Assistant Secretary for Preparedness and Response1 contract | $13,030,326 |
What they sell
| Industry | Amount | Share |
|---|---|---|
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 1 contract | $13,030,326 |
Where the work is
| Place of work | Amount | Share |
|---|---|---|
| Texas1 contract | $13,030,326 |
Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Office of Assistant Secretary for Preparedness and Response: see the list.
Get new notices like Chrysalis Biotherapeutics's work
New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.
Free. We use your email only for these alerts and never share it. Privacy